Carbon nitride-based nanocaptor: An intelligent nanosystem with metal ions chelating effect for enhanced magnetic targeting phototherapy of Alzheimer's disease.

Alzheimer's disease Aβ aggregation clearance Blood-brain barrier Copper ions capture Intelligent nanocaptors Targeted synergistic therapy

Journal

Biomaterials
ISSN: 1878-5905
Titre abrégé: Biomaterials
Pays: Netherlands
ID NLM: 8100316

Informations de publication

Date de publication:
01 2021
Historique:
received: 11 06 2020
revised: 29 09 2020
accepted: 20 10 2020
pubmed: 1 11 2020
medline: 25 5 2021
entrez: 31 10 2020
Statut: ppublish

Résumé

Metal ions imbalance, a well-established pathologic feature of alzheimer's disease (AD), ultimately results in the deposition of amyloid-β peptide (Aβ) proteins and Aβ-induced neurotoxicity. Herein, to overcome these hurdles, an intelligent Aβ nanocaptor with the capacity to chelate metal ions and targeted therapy is developed by anchoring carbon nitride (C

Identifiants

pubmed: 33129186
pii: S0142-9612(20)30729-8
doi: 10.1016/j.biomaterials.2020.120483
pii:
doi:

Substances chimiques

Amyloid beta-Peptides 0
Ions 0
Nitriles 0
cyanogen 534Q0F66RK
Copper 789U1901C5

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

120483

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Auteurs

Ling Gong (L)

Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Jiangsu, 221002, PR China; Department of Neurology, Affiliated Hospital of Xuzhou Medical University, Jiangsu, 221002, PR China.

Xing Zhang (X)

Department of Trauma and Reconstructive Surgery, RWTH Aachen University Hospital, Aachen, 52074, Germany.

Kezhen Ge (K)

Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Jiangsu, 221002, PR China; Department of Neurology, Affiliated Hospital of Xuzhou Medical University, Jiangsu, 221002, PR China.

Yiming Yin (Y)

Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Jiangsu, 221002, PR China; Department of Neurology, Affiliated Hospital of Xuzhou Medical University, Jiangsu, 221002, PR China.

Jeremiah Ong'achwa Machuki (JO)

Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Jiangsu, 221002, PR China.

Yun Yang (Y)

Nanomaterials and Chemistry Key Laboratory, Wenzhou University, Zhejiang, 325027, PR China.

Hengliang Shi (H)

Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Jiangsu, 221002, PR China.

Deqin Geng (D)

Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Jiangsu, 221002, PR China; Department of Neurology, Affiliated Hospital of Xuzhou Medical University, Jiangsu, 221002, PR China. Electronic address: gengdeqin@126.com.

Fenglei Gao (F)

Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Jiangsu, 221002, PR China. Electronic address: jsxzgfl@sina.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH